Watch CBS News

Princeton University To Use Unapproved Meningitis Vaccine For Students

PRINCETON, N.J. (CBSNewYork/AP) – Princeton University officials have decided to give students a meningitis vaccine that hasn't been approved in the U.S. in order to stop the spread of the disease.

The decision came Monday and the first doses are to be available next month.

Last week, the Food and Drug Administration approved importing the vaccine, Bexsero, for possible use on Princeton's campus in New Jersey. The vaccine is approved in Europe and Australia. It's the only vaccine for use against the type B meningococcal bacteria.

Princeton University To Use Unapproved Meningitis Vaccine For Students

Since March there have been a total of seven confirmed cases of the meningitis strain on the New Jersey campus, the most recent last week. No one has died.

As a result, the drug has been recommended for use on campus by Centers for Disease Control and Prevention.

The potentially deadly disease can be easily spread through close contact among people, making college students who live in dorms especially vulnerable. 

Under state law, anyone living in dorm rooms must have vaccinations against other strains of meningitis. The vaccinations, however, do not cover type B.

University officials are urging students to avoid spreading the disease by washing their hands, covering their mouths while coughing and making sure to not share items such as drinking glasses and eating utensils.

The vaccine will be made available for students who live in on-campus dorms, as well as some other members of the university community early next month. Two doses are required for maximum protection, the university said in a statement Monday evening.

The vaccine is not mandatory for students, and the university is covering the cost.

Bexsero is in the approval process in the U.S.

You May Also Be Interested In These Stories:

(TM and © Copyright 2013 CBS Radio Inc. and its relevant subsidiaries. CBS RADIO and EYE Logo TM and Copyright 2013 CBS Broadcasting Inc. Used under license. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press contributed to this report.)

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.